Targeted Medical Pharma, Inc.

TRGM · OTC
Analyze with AI
12/31/2015
9/30/2015
6/30/2015
3/31/2015
Operating Activities
Net Income-$605-$238-$546-$1,678
Dep. & Amort.$54$52$58$68
Deferred Tax$0$0$0$0
Stock-Based Comp.$7$16$42$30
Change in WC$392$260$419$42
Other Non-Cash$228$43$2$77
Operating Cash Flow$77$132-$26-$1,461
Investing Activities
PP&E Inv.$0$0$0-$4
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$4
Financing Activities
Debt Repay.-$15-$133-$180$1,677
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$15-$133-$180$1,677
Forex Effect$0$0$0$0
Net Chg. in Cash$62-$1-$202$211
Supplemental Information
Beg. Cash$21$21$223$12
End Cash$83$21$21$223
Free Cash Flow$77$132-$22-$1,465